LAZARD ASSET MANAGEMENT LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$34
+6.2%
1,722
+4.8%
0.00%
Q2 2023$32
+23.1%
1,643
+2.8%
0.00%
Q1 2023$26
+8.3%
1,598
+25.0%
0.00%
Q4 2022$24
-99.9%
1,278
-22.0%
0.00%
Q3 2022$25,000
+19.0%
1,638
+0.3%
0.00%
Q2 2022$21,000
-12.5%
1,633
+4.3%
0.00%
Q1 2022$24,0000.0%1,566
+37.9%
0.00%
Q4 2021$24,000
-11.1%
1,136
+20.7%
0.00%
Q3 2021$27,000
-55.7%
941
-33.0%
0.00%
Q2 2021$61,000
+2950.0%
1,404
+2708.0%
0.00%
Q1 2021$2,0000.0%500.0%0.00%
Q4 2020$2,000
-99.9%
50
-99.9%
0.00%
-100.0%
Q3 2018$1,715,00069,6810.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders